Youngbo Chemical영보화학
014440 · KOSPI · ₩014440 · 영보화학
₩4,695▲ ₩10 (0.21%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩32B | ₩28B | ₩34B | ₩31B | ₩29B | ₩26B | ₩34B | ₩29B |
| Cost of sales | ₩22B | ₩21B | ₩23B | ₩22B | ₩20B | ₩19B | ₩23B | ₩20B |
| Gross profit | ₩9.5B | ₩7.4B | ₩11B | ₩9B | ₩9B | ₩7.6B | ₩11B | ₩8.5B |
| Operating income | ₩5.1B | ₩3.1B | ₩6.3B | ₩4.8B | ₩4.7B | ₩3.4B | ₩5.8B | ₩4.6B |
| Net income | ₩1.3B | ₩3.1B | ₩12B | ₩1.9B | −₩927M | ₩3.5B | ₩19B | −₩997M |
| Net income to shareholders | ₩4.5B | ₩3.1B | ₩6.2B | ₩4.5B | ₩2.6B | ₩3.5B | ₩8B | ₩3.7B |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩216B | ₩214B | ₩211B | ₩206B | ₩195B | ₩202B | ₩203B | ₩195B |
| Current assets | ₩108B | ₩109B | ₩106B | ₩104B | ₩95B | ₩101B | ₩100B | ₩94B |
| Cash and equivalents | ₩9.5B | ₩12B | ₩7.8B | ₩12B | ₩15B | ₩25B | ₩14B | ₩18B |
| Total liabilities | ₩19B | ₩23B | ₩19B | ₩20B | ₩16B | ₩22B | ₩20B | ₩19B |
| Current liabilities | ₩19B | ₩23B | ₩19B | ₩20B | ₩16B | ₩22B | ₩19B | ₩19B |
| Borrowings | — | — | ₩0 | — | — | — | ₩0 | ₩130M |
| Total equity | ₩197B | ₩191B | ₩191B | ₩186B | ₩179B | ₩180B | ₩183B | ₩176B |
| Shareholders' equity | ₩197B | ₩191B | ₩191B | ₩186B | ₩179B | ₩180B | ₩183B | ₩176B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | ₩13B | ₩4.1B | ₩2B | ₩5.1B | ₩4.5B | ₩3.8B | ₩691M | ₩8B |
| Capital spending | ₩3.3B | ₩3.4B | ₩1.8B | ₩2.1B | ₩2.2B | ₩1.3B | ₩1.6B | ₩1.9B |
| Free cash flow | ₩9.5B | ₩766M | ₩156M | ₩2.9B | ₩2.3B | ₩2.5B | −₩904M | ₩6.1B |
| Dividends paid | ₩6.8B | ₩0 | ₩0 | ₩0 | ₩6.8B | ₩0 | ₩0 | ₩0 |
Consolidated where available. Amounts in won.
Also known as: Youngbo Chemical / 영보화학 / 014440 / KRX:014440
Source: KRX statistical information